期刊文献+

TGF-β信号通路在神经退行性疾病中的作用研究进展 被引量:1

Research Progress on the Role of TGF-β Signaling Pathway in Neurodegenerative Diseases
原文传递
导出
摘要 神经退行性疾病是由于各种原因导致的机体神经元或髓鞘进行性丢失,最终出现功能障碍的一类预后极差且无法治愈的疾病。转化生长因子-β(TGF-β)信号通路可以调控多种细胞过程,包括细胞的生长、分化、凋亡等,在维持机体正常发育和动态平衡中具有重要作用。既往的研究表明,TGF-β信号通路与神经退行性疾病的发生发展与治疗存在密切联系,但其机制仍未完全明确。该文介绍了TGF-β信号通路在多种神经退行性疾病中的最新研究进展,以期为神经退行性疾病的预防、诊断和治疗提供新思路。 Neurodegenerative diseases are a type of diseases with poor prognosis and incurable in which the body’s neurons or myelinations are progressively lost due to various reasons,and eventually dysfunction occurs.TGF-β (transforming growth factor-β) signaling pathway can regulate a variety of cellular processes,including cell growth,cell differentiation,cell apoptosis,etc.,and plays an important role in maintaining normal development and homeostasis of the body.Previous studies have shown that the TGF-β signaling pathway is closely related to the occurrence,development and treatment of neurodegenerative diseases.This paper introduces the latest research progress of TGF-β signaling pathway in various neurodegenerative diseases,in order to provide new ideas for the prevention,diagnosis and treatment of neurodegenerative diseases.
作者 芦怡 张立涵 潘煦一 方圆媛 颜悦 汪伟 苗雪萌 黄智慧 LU Yi;ZHANG Lihan;PAN Xuyi;FANG Yuanyuan;YAN Yue;WANG Wei;MIAO Xuemeng;HUANG Zhihui(The First Clinical Medical College,Wenzhou Medical University,Wenzhou 325035,China;The Second Clinical Medical College,Wenzhou Medical University,Wenzhou 325035,China;School of Mental Health,Wenzhou Medical University,Wenzhou 325035,China;School of Medicine,Hangzhou Normal University,Hangzhou 31l121,China)
出处 《中国细胞生物学学报》 CAS CSCD 2022年第10期1995-2005,共11页 Chinese Journal of Cell Biology
基金 国家级大学生创新创业训练计划(批准号:202010343039)资助的课题。
关键词 神经退行性疾病 转化生长因子-Β 信号通路 作用机制 neurodegenerative diseases transforming growth factor-β signaling pathway mechanism of action
  • 相关文献

参考文献2

二级参考文献62

  • 1Casey G. Alzheimer's and other dementias. Nurs N Z. 2012;18:20 24.".
  • 2Povova J, Ambroz P, Bar M, et al. Epidemiological of and risk fac tors for Alzheimer's disease: a review. Biomed Pap Med Fac Uni?Palacky Olomouc Czech Repub. 2012; 156: 108-114.
  • 3Bassil N, Mollaei C. Alzheimer's dementia: a brief review. J Mer Liban.2012;60:192-199.
  • 4Singh S, Kushwah AS, Singh R, et al. Current therapeutic strateg in Alzheimer's disease. Eur Rev Med Pharmacol Sci. 2012;16:1651 1664.
  • 5Walsh DM, Teplow DB. Alzheimer's disease and the amyloid be ta-protein. Prog Mol BioI Transl Sci. 2012;107:101-124.
  • 6Sagare AP, Bell RD, Zlokovic BV. Neurovascular defects and fault: amyloid-B vascular clearance in Alzheimer's disease. J Alzheimer: Dis. 2013;33 Suppll:S87-100.
  • 7Roberts AB, Anzano MA, Wakefield LM, et al. Type beta trans forming growth factor: a bifunctional regulator of cellular growth Proc Nat! Acad Sci USA. 1985;82:119-123.
  • 8Brown JP, Twardzik DR, Marquardt H, et al. Vaccinia virus en codes a polypeptide homologous to epidermal growth factor ant transforming growth factor. Nature. 1985;313:491-492.
  • 9Araujo-Jorge TC, Waghabi MC, Bailly S, et al. The TGF-beta path way as an emerging target for Chagas disease therapy. Clin Pharo macol Ther. 2012;92:613-62l.
  • 10Sakaki-Yumoto M, Katsuno Y, Derynck R. TGF-beta family signal ing in stem cells. Biochim Biophys Acta. 2013;1830:2280-2296.

共引文献52

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部